Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4337 USD | -1.43% | -5.41% | -38.13% |
May. 10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Financials (USD)
Sales 2022 | 1.68M | Sales 2023 | 1.93M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2022 | -105M | Net income 2023 | -62M | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M | Net Debt 2023 | 43.43M | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.82% |
1 day | -1.43% | ||
1 week | -5.41% | ||
Current month | -6.73% | ||
1 month | -10.58% | ||
3 months | -19.70% | ||
6 months | -38.61% | ||
Current year | -38.13% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.4337 | -1.43% | 1,764,144 |
24-05-24 | 0.44 | -2.65% | 2,330,162 |
24-05-23 | 0.452 | -0.96% | 1,448,325 |
24-05-22 | 0.4564 | -0.47% | 2,880,431 |
24-05-21 | 0.4585 | -0.11% | 1,289,166 |
Delayed Quote OTC Markets, May 28, 2024 at 03:58 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-38.13% | 526M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.11% | 21.83B | |
-11.21% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- NWBO Stock